Evidence map›Paper›PMID 34449757›Full record

ArticleTropical medicine and infectious disease2021

An Autochthonous Outbreak of the SARS-CoV-2 P.1 Variant of Concern in Southern Italy, April 2021.

Daniela Loconsole, Anna Sallustio, Francesca Centrone, Daniele Casulli, Maurizio Mario Ferrara, Antonio Sanguedolce, Marisa Accogli, Maria Chironna

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. COVID-19: Current Status and Future Prospects.Tropical medicine and infectious disease · 2023
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Daniela LoconsoleDepartment of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.ORCID 0000-0003-2057-9745
Anna SallustioHygiene Unit, University Hospital Consortium Policlinico, 70124 Bari, Italy.
Francesca CentroneDepartment of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.ORCID 0000-0003-3018-5408
Daniele CasulliHygiene Unit, University Hospital Consortium Policlinico, 70124 Bari, Italy.
Maurizio Mario FerraraLocal Health Unit of Bari, Department of Prevention, 70132 Bari, Italy.
Antonio SanguedolceLocal Health Unit of Bari, Department of Prevention, 70132 Bari, Italy.
Marisa AccogliDepartment of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.
Maria ChironnaDepartment of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.ORCID 0000-0002-1043-1256
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 P.1 variant of concern (VOC) was first identified in Brazil and is now spreading in European countries. It is characterized by the E484K mutation in the receptor-binding domain, which could contribute to the evasion from neutralizing antibodies. In Italy, this variant was first identified in January 2021. Here, we report an autochthonous outbreak of SARS-CoV-2 P.1 variant infections in southern Italy in subjects who had not travelled to endemic areas or outside the Apulia region. The outbreak involved seven subjects, three of whom had received a COVID-19 vaccine (one had received two doses and two had received one dose). Four patients had a mild clinical presentation. Laboratory investigations of nasopharyngeal swabs revealed that all strains were S-gene target failure-negative and molecular tests revealed they were the P.1 variant. Whole-genome sequencing confirmed that five subjects were infected with closely related strains classified as the P.1 lineage. The circulation of VOCs highlights the importance of strictly monitoring the spread of SARS-CoV-2 variants through genomic surveillance and of investigating local outbreaks. Furthermore, public health measures including social distancing, screening, and quarantine for travelers are key tools to slow down the viral transmission and to contain and mitigate the impact of VOC diffusion, and rapid scaling-up of vaccination is crucial to avoid a possible new epidemic wave.

Indexed as

COVID-19Gamma variantoutbreakP.1 variantSARS-CoV-2 infectionwhole-genome sequencing

Identifiers

PMID34449757
PMCPMC8396329
OpenAlexW3189107097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.